Myelopathy due to intrathecal chemotherapy in a pacient with acute lymphoblastic leukemia [2];Mielopatía secundaria a la administración de quimioterapia intratecal en un paciente con leucemia aguda linfoblástica

Medicina Clinica

Volumn 126, Issue 2, 2006, Pages 76-

  Piernas, Sònia ^a   Sancho, Juan M ^a   Battle, Montserrat ^a   Ribera, Josep M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARAGINASE; ASPARTATE AMINOTRANSFERASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; HYDROCORTISONE; LACTATE DEHYDROGENASE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; PYRIDOXINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; CASE REPORT; CENTRAL NERVOUS SYSTEM; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LETTER; MALE; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; SPINAL CORD DISEASE; SUBDURAL HEMATOMA; URINE INCONTINENCE;

EID: 32844464870     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13083572     Document Type: Letter

References (10)

1. Pinkel D, Woo S. Prevention and treatment of meningeal leukemia in children. Blood. 1994;84:355-66.
2. Bay A, Faik A, Etlik O, Yilmaz C, Caksen H. Myelopathy due to intrathecal chemotherapy. Report of six cases. J Pediatr Hematol Oncol. 2005-27: 270-2.
3. Ribera JM, Oriol A, Sanz MA, Abella E, Tormo M, Del Potro E, et al. Results of PETHEMA ALL protocol for standard risk adult ALL patients. Hematology J. 2004;5 Suppl 2:134.
4. McLean DR, Clink HM, Ernst P, Coates R, Al Kawi MZ, Bohlega S, et al. Myelopathy after intrathecal chemotherapy. A case report with unique magnetic resonance imaging changes. Cancer. 1994;73:3037-40.
5. Rubnitz JE, Relling MV, Harrison PL, Sandlund JT, Ribeiro RC, Rivera GK, et al. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukaemia. Leukemia. 1998;12:1176-81.
6. Vogel H, Horoupian DS. Filamentous degeneration of neurons. A possible feature of cytosine arabinoside neurotoxicity. Cancer. 1993;71:1303-8.
7. Resar LM, Phillips PC, Kastan MB, Leventhal BG, Bowman PW, Civin CI. Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type. Cancer. 1993;71:117-23.
8. Watterson J, Toogood I, Nieder M, Morse M, Frierdich S, Lee Y, et al. Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer. 1994;74:3034-41.
9. García-Tena J, López-Andreu JA, Ferris J, Menor F, Mulas F, Mollet E, et al. Intrathecal chemotherapy-related myeloencephalopathy in a young child with acute lymphoblastic leucemia. Pediatr Hematol Oncol. 1995;12:377-85.
10. Drachtman RA, Cole PD, Golden CB, Jill S, Melnyk S, Aisner J, et al. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol. 2002;19:319-27.